Previous close | 30.70 |
Open | 30.70 |
Bid | 37.30 |
Ask | 40.80 |
Strike | 155.00 |
Expiry date | 2024-06-21 |
Day's range | 30.70 - 30.70 |
Contract range | N/A |
Volume | |
Open interest | 5 |
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
Matthew Dolan, Executive Vice President of Strategy and Corporate Development at DexCom Inc (NASDAQ:DXCM), sold 2,423 shares of the company on May 15, 2024.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.